Batch: Spring 2022
Contact person: Aarno Dietz
Batch: Spring 2022
Light- reconfigurable substrate for cell cultures
Contact person: Arri Priimägi
Batch: Spring 2022
Mental health services
Contact person: Eero Haikonen
Batch: Spring 2022
Contact person: Benedek Poor
Batch: Spring 2022
Bio-armored Mitochondria Initiate a Fundamental Therapeutic Era Beyond Horizon
Contact person: Hongbo Zhang
Batch: Spring 2022
An automated and scalable computational tool for precision cancer diagnosis and personalized treatment selection
Contact person: Karolina Punovuori
Batch: Fall 2021
AI for the detection of heart transplant rejection
Contact person: Juha Peltonen
Batch: Fall 2021
Improving patient safety by monitoring: novel method for diagnosing respiratory suppression
Contact person: Antti Vehkaoja
Batch: Fall 2021
Non-invasive and non-pharmacological solution to support rehabilitation from AUD
Contact person: Jukka Planman
Batch: Fall 2021
Diaper embedded biosensor platform, that screens abnormal clinical conditions
Contact person: Oguz Tanzer
Batch: Fall 2021
Prevention of pressure ulcers
Contact person: Nuno Nobre
Batch: Fall 2021
Viability analysis of organ transplants, and neuronal and cardiac implants
Contact person: Jarno Tanskanen
Batch: Fall 2021
Smart core needle for ensuring successful biopsy procedure
Contact person: Maria Lavonen
Batch: Fall 2021
In vitro diagnostic test that predicts which patients will benefit from immunotherapy
Contact person: Juho Pokki
Batch: Fall 2021
How to make vaccines thermostable
Contact person: Manlio Fusciello
Batch: Spring 2021
Rapid diagnostics of human picornaviruses based on viral proteases
Contact person: Petri Susi
Batch: Spring 2021
Characterizing aptamer—the next generation of affinity ligand
Contact person: Yike Huang
Batch: Spring 2021
Novel method for histology
Contact person: Ilkka Paatero
Batch: Spring 2021
Oral microbiome imaging system
Contact person: Sepideh Parvanian
Batch: Spring 2021
mTMS – multilocus transcranial magnetic stimulation
Contact person: Kicic Dubravko
Batch: Spring 2021
Mathematic algorithm for personalized prediction of the risk for aortic dilatation and rupture
Contact person: Marja Hedman
Batch: Spring 2021
Detection of Corrosion from Stainless Steel Implements.
Contact person: Juho Lehmusto
Batch: Spring 2021
Poly(jasmine lactone): A Versatile Platform for Drug Delivery
Contact person: Kuldeep Bansal
Batch: 2020
Method for objective assessment of infant motor development.
Contact person: Sampsa Vanhatalo
Batch: 2020
Tissue specific therapy for skin diseases
Contact person: Tero Järvinen
Batch: 2020
Platform for optimized production of biotechnological proteins
Contact person: Ville Paavilainen
Batch: 2020
Cognitive assessment in virtual reality
Contact person: Susanna Stjerna
Batch: 2020
Quantifying Epilepsy
Contact person: Veikko Jousmäki
Batch: 2020
Functional brain imaging reshaped
Contact person: Marko Havu
Batch: 2020
A Novel Cell Growth Matrix by 3D Printing of Biopolymers
Contact person: Chunlin Xu
Batch: 2020
Accurate correction for QT interval ‒ the most important cardiac risk measure.
Contact person: Esa Räsänen
Batch: 2020
Functional insight into hypercholesterolemia patients (former HyperFunc project).
Contact person: Simon Pfisterer
Batch: 2020
Implantable mesh to treat pelvic organ prolapse
Contact person: Jani Kuula
Batch: Spring 2018
Microbiome based therapy for Parkinson’s disease.
A contract with a large company
Contact person: Filip Scheperjans
Batch: Fall 2017
Tissue analysis for breast cancer surgery.
Spin out to Olfactomics Oy
Contact person: Antti Roine
Batch: Pilot 2016 / Spring 2017
Nano structure for bioimaging.
Spin-out to XFold Imaging Oy
Contact person: Timo Jäntti
Batch: Pilot 2016 / Spring 2017
Caries and infection prevention and treatment.
Spin-out to Koite Health Oy
Contact person: Tommi Pätilä
Batch: Pilot 2016 / Spring 2017
Safety mechanism for surgical drills.
Spin-out to Surgify Medical Oy
Contact person: Visa Sippola
Batch: Fall 2018
Laboratory and computational method for liquid biopsies.
Spin-out to Genomill Health Oy
Contact person: Manu Tamminen
Batch: Fall 2018
Rational discovery of protein-protein interaction modulators.
Spin-out to Aurlide Oy
Contact person: Olli Pentikäinen
Batch: Spring 2018
Light controlled protein production.
An alumni due Project Manager got recruited to Bayer.
Contact person: Jari Rossi
Batch: Spring 2018
Extra cellular vesicle solution for bleeding disorders.
An alumni due Project Manager got recruited to Mayo Clinic (USA).
Contact person: Mayank Saraswat
Batch: Spring 2018
Novel single cell omics methods.
Spin-out to Scellex Oy
Contact person: Päivi Saavalainen
Batch: Fall 2017
Laser solution for eye treatment.
Became a development case for industry.
Contact person: Jukka Viheriälä
Batch: Spring 2017
Peritoneal diagnostics for dialysis patients.
Spin-out to Smart PD Solutions Oy
Contact person: Pirgit Silvast-Äikäs
Batch: Pilot 2016 / Spring 2017
Cancer drug for GIST.
Spin out to Sartar Therapeutics Oy
Contact person: Harri Sihto
Batch: 2019
High-quality vertigo diagnostics for primary care physicians.
Alumni due got a funding for another project.
Contact person: Tuomas Hyytiä
Batch: Spring 2018
Method for extra-cellular vesicle isolation.
Spin-out under establishment
Contact person: Maija Puhka
Batch: Spring 2018
Method to monitor the oxygenation of myocardial tissue.
Spin-out to SpectroCor Oy
Contact person: Kalle Kotilahti
Batch: Spring 2018
Novel heat treatment for age related macular degeneration.
Spin-out to Maculaser Oy
Contact person: Jani Tirronen
Batch: Spring 2018
Mycobacterial biofilms as anti-tuberculosis drug targets.
Became a cornerstone of an extensive multinational research program (FIN, AUS, U.S., ZA...)
Contact person: Mataleena Parikka
Batch: Spring 2018
Light-activated antimicrobial surfaces and materials.
IP acquired by Plasmonics Oy
Contact person: Alexandre Efimov
Batch: Fall 2017
Toxicity test for heart cells (FICAM based stem cell model).
Became a new solution for toxicity testing for FICAM.
Contact person: Tuula Heinonen
Batch: Spring 2017
Ocular biomarker panel and analysis.
Spin-out under establishment
Contact person: Ulla Aapola
Batch: Spring 2017
Microbiological Analyses on (Blue) Bio- and Circular Economies.
Spin-out to GreenSeq Oy
Contact person: Kirsi-Maarit Lehto
Batch: 2020
Cardiac Micrograft Therapy™ for treating Ischhemic Scars and Heart Failure.
Spin-out to EpiHeart Oy.
Contact person: Kai Kronström
Batch: 2020
Long-term oral drug delivery.
Alumni due Prof. Helder Santos got recruited as Head of Biomedical Engineering at UMCG (Groningen, NED).
Contact person:
Batch: 2020
Natural medication for human papillomavirus (HPV)-associated warts.
Spin-out to Anison Therapeutics Oy
Contact person: Preethy Paul
Batch: 2020
Personalized treatment planning of osteoarthritis.
Spin-out to Algoa Progress.
Contact person: Joona Kemppainen
Batch: 2019
Novel treatment for limbal epithelial stem cell deficiency.
Spin-out to StemSight Oy
Contact person: Laura Koivusalo
Batch: 2019
Topographically tuned and sustainable surfaces for biological applications.
Alumni due project manager got recruited as Innovation Manager at University of Turku.
Contact person: Erik Niemelä
Batch: Spring 2018
Microbiome based diagnostics for Parkinson’s disease.
Joint development and licensing agreement.
Contact person: Filip Scheperjans
Batch: Fall 2017
AI solution for toxicity testing.
Solution in pilot use in industry.
Contact person: Dario Greco
Batch: 2020
Smart heart monitoring.
Spin-out to Sonai Health Oy.
Contact person: Arto Kotimaa
Batch: 2020
Indoor air diagnostics with fluorescent C. elegans nematodes.
Lead to a co-research project.
Contact person: Päivi Koskinen
Batch: 2019
Therapeutics for antimicrobial resistant bacteria.
VIRI became Arivin Therapeutics and was accepted to German/Swiss INCATE Incubator.
Contact person: Christopher Jonkergouw
Batch: 2019
Distal radius fractures artificial intelligence diagnostic tool.
Preparations for a startup in progress.
Contact person: Jorma Ryhänen
Batch: 2019
Ultrasound solution for cancer biopsies
Spin-out/licensing under development.
Contact person: Jouni Rantanen
Batch: 2019
Simple droplet devices for biomedicine, diagnostics and pharma.
Got continuing development funding.
Contact person: Päivi Saavalainen
Batch: 2019
Diagnostic test for vitamin B3 metabolism deficiency.
Spin-out to NADMED Oy
Contact person: Liliya Euro
Batch: Fall 2018
Parkinson’s signature biomarker assay.
Ongoing large validation study, new things emerging with MJFF funding.
Contact person: Eleanor Coffey